Low Performance of Sinovac Vaccine Particularly With Belatacept Therapy in a Study With Different Types of COVID-19 Vaccines in Transplanted Patients.

导出 OA

翻译打印收藏纠错

作者： Yazmin Rocio,Arias-Murillo ^[1] ; María Angélica,Salinas-Nova ^[2] ; Tatiana,Caicedo ^[2] ; Marisol,Galindo-Borda ^[3] ; Ximena,Meneses-Gil ^[4] ; Camilo,Montero ^[5] ; Fernando,Giron ^[6] ; Nestor,Pedraza ^[6] ; Gustavo,Aroca ^[7] ; Martha Lucìa,Ospina-Martinez ^[8] ; Marcela,Mercado-Reyes ^[9]

作者单位： National Coordination of the Donation and Transplant Network, Blood Bank, Transfusion, and Transplant Research Group, National Institute of Health, Bogotá, Colombia. Electronic address: yarias@ins.gov.co. ^[1] National Coordination of the Donation and Transplant Network, Blood Bank, Transfusion, and Transplant Research Group, National Institute of Health, Bogotá, Colombia. ^[2] Emerging Microorganism Genomics Group, National Institute of Health, Bogotá, Colombia. ^[3] National Institute of Health, Bogotá, Colombia. ^[4] Transplant Program, Colombia University Clinic, Bogotá, Colombia. ^[5] Department of Transplant Surgery, Colombiana de Transplantes, Bogotá, Colombia. ^[6] Transplant Group, Simon Bolivar University, Clinica de la Costa, Barranquilla, Colombia. ^[7] Jorge Tadeo Lozano University, National Institute of Health, Bogotá, Colombia. ^[8] Public Health Research, National Institute of Health, Bogotá, Colombia. ^[9]

主题词人类(Humans);抗体(Antibodies);抗体, 病毒(Antibodies, Viral);免疫抑制剂(Immunosuppressive Agents);接种(Vaccination)

DOI 10.1016/j.transproceed.2023.02.034

PMID 36997378

发布时间 2023-05-17

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交